| Updating and Validating the US Veterans Affairs Frailty Index: Transitioning From ICD-9 to ICD-10 D Cheng, C DuMontier, C Yildirim, B Charest, CE Hawley, M Zhuo, ... The Journals of Gerontology: Series A 76 (7), 1318-1325, 2021 | 76 | 2021 |
| Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment R Ayyagari, W Wei, D Cheng, C Pan, J Signorovitch, EQ Wu Value in Health 18 (2), 198-205, 2015 | 47 | 2015 |
| Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System J La, D Cheng, MT Brophy, NV Do, JSH Lee, D Tuck, NR Fillmore JCO clinical cancer informatics 4, 918-928, 2020 | 38 | 2020 |
| The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large US academic center analysis FO Marcondes, D Cheng, ET Warner, SC Kamran, JS Haas Preventive Medicine 151, 106640, 2021 | 37 | 2021 |
| Safety and efficacy of tumor necrosis factor antagonists in older patients with ulcerative colitis: patient-level pooled analysis of data from randomized trials D Cheng, KC Cushing, T Cai, AN Ananthakrishnan Clinical Gastroenterology and Hepatology 19 (5), 939-946. e4, 2021 | 37 | 2021 |
| Robust and efficient semi‐supervised estimation of average treatment effects with application to electronic health records data D Cheng, AN Ananthakrishnan, T Cai Biometrics 77 (2), 413-423, 2021 | 31 | 2021 |
| Robust and efficient semi‐supervised estimation of average treatment effects with application to electronic health records data D Cheng, AN Ananthakrishnan, T Cai Biometrics 77 (2), 413-423, 2021 | 31 | 2021 |
| Understanding the link between obesity and severe COVID-19 outcomes: Causal mediation by systemic inflammatory response AS Foulkes, C Selvaggi, D Shinnick, H Lumish, E Kim, T Cao, ... The Journal of Clinical Endocrinology & Metabolism 107 (2), e698-e707, 2022 | 29 | 2022 |
| Risk of infections with ustekinumab and tofacitinib compared to tumor necrosis factor α antagonists in inflammatory bowel diseases D Cheng, B Kochar, T Cai, AN Ananthakrishnan Clinical Gastroenterology and Hepatology, 2022 | 27 | 2022 |
| Adaptive Combination of Randomized and Observational Data D Cheng, T Cai arXiv preprint arXiv:2111.15012, 2021 | 27 | 2021 |
| Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases BD Kochar, D Cheng, T Cai, AN Ananthakrishnan Digestive Diseases and Sciences, 1-7, 2022 | 26 | 2022 |
| Comorbidity influences the comparative safety of biologic therapy in older adults with inflammatory bowel diseases D Cheng, B Kochar, T Cai, CS Ritchie, AN Ananthakrishnan Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 24 | 2022 |
| A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis F Pellegrini, M Copetti, F Bovis, D Cheng, R Hyde, C de Moor, ... Multiple Sclerosis Journal 26 (9), 1064-1073, 2020 | 23 | 2020 |
| Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD SX Sun, M Marynchenko, R Banerjee, D Cheng, M Mocarski, D Yin, ... Journal of medical economics 14 (6), 805-815, 2011 | 22 | 2011 |
| The statistical performance of matching-adjusted indirect comparisons: Estimating treatment effects with aggregate external control data D Cheng, R Ayyagari, J Signorovitch The Annals of Applied Statistics 14 (4), 1806-1833, 2020 | 20 | 2020 |
| Estimating average treatment effects with a double‐index propensity score D Cheng, A Chakrabortty, AN Ananthakrishnan, T Cai Biometrics 76 (3), 767-777, 2020 | 19 | 2020 |
| Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare System C DuMontier, NR Fillmore, C Yildirim, D Cheng, J La, AR Orkaby, ... Cancers 13 (12), 3053, 2021 | 18 | 2021 |
| Defining multimorbidity and its impact in older united states veterans newly treated for multiple myeloma NR Fillmore, C DuMontier, C Yildirim, J La, MM Epstein, D Cheng, ... JNCI: Journal of the National Cancer Institute 113 (8), 1084-1093, 2021 | 16 | 2021 |
| Developing a risk score to guide individualized treatment selection in attention deficit/hyperactivity disorder J Setyawan, H Yang, D Cheng, X Cai, J Signorovitch, J Xie, MH Erder Value in Health 18 (6), 824-831, 2015 | 12 | 2015 |
| Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics JS Haas, D Cheng, L Yu, SJ Atlas, C Clark, S Feldman, MI Silver, ... Preventive medicine 154, 106871, 2022 | 11 | 2022 |
